Status:
COMPLETED
Social Norms, Messengers, and Processing Fluency to Increase Hypertension Medication Adherence
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Humana Inc.
National Institute on Aging (NIA)
Conditions:
Medication Adherence
Hypertension
Eligibility:
All Genders
65-79 years
Phase:
NA
Brief Summary
Medicare Advantage beneficiaries ages 65-79 and insured by Humana with at least two unique fills of hypertension medication within the 2023 calendar year and adherence level between 60 and 85% will be...
Eligibility Criteria
Inclusion
- Medicare Advantage beneficiary insured by Humana
- Between the ages of 65 and 79
- Having at least two unique fills of any class of hypertension medication within the calendar year (2023).
- Adherence level (as measured by the proportion of days covered \[PDC\] metric) between 60% and 85%
Exclusion
- Beneficiaries in plans which, per contractual agreements, privacy policies and rules, or legal requirements, do not participate in research
Key Trial Info
Start Date :
August 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
65177 Patients enrolled
Trial Details
Trial ID
NCT06066541
Start Date
August 18 2023
End Date
December 31 2023
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Humana, Inc.
Louisville, Kentucky, United States, 40202